Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India
new CDSCO-Invitation for RFP Selection of Software Service Provider (SSP) for Design, Development, Implementation, Operation & Maintenance of Digital Drugs Regulatory System(DDRS): Corrigendum issued - C1 | Bid No. GEM/2026/B/7383439 (Dated 24-04-2026)- An erroneously uploaded document has been corrected. Please refer to the latest corrigendum on GeM. Last Date: 13 May 2026 newDisposal / Rejection of Long-Pending Applications on Sugam Portal Awaiting Query Response newInviting comments on Revised Guidelines on Similar Biologics- Regulatory requirements for Marketing Authorization in India 2025 drafted by CDSCO newReport your Quality Related Complaint for All Drugs Including Vaccines new CDSCO – IndiaAI Mission Health Innovation Acceleration Hackathon has been extended to 30 April 2026 newVacancy for post of Director in RDTL Chandigarh newVacancy for Deputy Director in RDTL Guwahati newVacancy for Senior Assistant (Admn) in CDSCO newNumber of Cough syrup sample for Export at Different Laboratories for testing new Regulation of all Class A & B Medical Devices under Licensing regime, w.e.f 01.10.2022, as per G.S.R. 102(E) dt 11.02.2020 new GSR 754 (E) 30-09-2022 Sale of Medical Device Retail and wholesale newAll the stakeholders are requested to voluntarily fill and submit customer feedback form available in the website while visiting PRO at CDSCO (HQ) new Notice regarding Guidance for approval Covid-19 vaccine in India for restricted use in emergency situation which are already approved for restricted use by US FDA EMA, UK MHRA, PMDA Japan or which are listed in WHO Emergency use listing 15th April,2021 DCGI Message 202101 Jan 2021 E-GOV cell at CDlSCO

The Central Drugs Standard Control Organisation(CDSCO)under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India. Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and also has six zonal offices,four sub zonal offices,thirteen Port offices and seven laboratories spread across the country.
The Drugs & Cosmetics Act,1940 and rules 1945 have entrusted various responsibilities to central & state regulators for regulation of drugs & cosmetics.It envisages uniform implementation of the provisions of the Act & Rules made there under for ensuring the safety, rights and well being of the patients by regulating the drugs and cosmetics. CDSCO is constantly thriving upon to bring out transparency, accountability and uniformity in its services in order to ensure safety, efficacy and quality of the medical product manufactured, imported and distributed in the country.
Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.
Further CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.

Divisions